The presence of anti-citrullinated protein antibodies (acpa) does not affect the clinical response to adalimumab in a group of ra patients with the tumor necrosis factor (tnf) alpha-308 g/g promoter polymorphism

CLINICAL RHEUMATOLOGY;
CLIN RHEUMATOL

dc.creatorSoto, Lilian
dc.creatorSabugo, Francisca
dc.creatorCatalan, Diego
dc.creatorWurmann, Pamela
dc.creatorCermenatti, Tomas
dc.creatorGatica, Hector
dc.creatorAravena, Octavio
dc.creatorSalazar, Lorena
dc.creatorCarlos Aguillon, Juan
dc.creatorCuchacovich, Miguel
dc.date2011
dc.date2016-11-29T19:28:51Z
dc.date2022-07-05T18:34:18Z
dc.date2016-11-29T19:28:51Z
dc.date2022-07-05T18:34:18Z
dc.date2011
dc.date.accessioned2023-08-23T00:17:52Z
dc.date.available2023-08-23T00:17:52Z
dc.identifier1040439
dc.identifier1040439
dc.identifier0770-3198
dc.identifierhttps://hdl.handle.net/10533/127837
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8354580
dc.description7
dc.descriptionFONDECYT
dc.descriptionmcuchaco@gmail.com
dc.description3
dc.descriptionFONDECYT
dc.description30
dc.languageeng
dc.publisherSPRINGER LONDON LTD
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.relationinfo:eu-repo/grantAgreement/Fondecyt/1040439
dc.relationinfo:eu-repo/semantics/dataset/hdl.handle.net/10533/93477
dc.relationhttps://doi.org/10.1007/s10067-011-1679-4
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleThe presence of anti-citrullinated protein antibodies (acpa) does not affect the clinical response to adalimumab in a group of ra patients with the tumor necrosis factor (tnf) alpha-308 g/g promoter polymorphism
dc.titleCLINICAL RHEUMATOLOGY
dc.titleCLIN RHEUMATOL
dc.typeArticulo
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.coverageLONDON


Este ítem pertenece a la siguiente institución